Edinburgh-based Craneware plc, a provider of software for the US healthcare market, said its revenue increased 9% to $205.7 million in the year ended June 30, 2025.

Craneware said its statutory profit before tax rose 52% to $24 million “benefitting from the reduction in finance costs driven by the group’s treasury management policy.”

Total dividend for the year is up 10% to 32p per share.

Craneware CEO Keith Neilson said: “FY25 was a proud milestone, not just due to the strength of the financial performance, but for what that growth represents: the tireless efforts by our team in the service of our hospital customers and the communities they serve.

“The year has seen us deliver on our commitment to increase our growth rate, while maintaining strong profit margins, reducing bank debt, increasing our dividend and providing an admirable return on our customers’ investment in the Group’s software.

“We continue to invest in R&D to strengthen our product set, leveraging our proprietary data assets to expand our offerings, launch new AI enabled applications and integrate third-party solutions onto the Trisus platform. Meanwhile, our partnership with Microsoft is proving a success, accelerating sales cycles and driving further innovation.

“Trading in the current year has started well, and with high customer retention rates, market leading offerings, specialist healthcare expertise and a significant proprietary data set, we have strong foundation on which to build.

“The growth in both ARR and NRR in the year demonstrates the strength of our Annuity SaaS business model, backed by multi-year contracts, providing a basis for growth acceleration in the year to come, and we look to the future with confidence.”